WOODBURY, N.Y.--(BUSINESS WIRE)--BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced it will share new research and practical approaches to help drug developers select fit-for-purpose models for increasingly complex therapeutic programs at several scientific events this fall. Through presentations, posters, and an upcoming webinar, BioIVT experts will address emerging questions related to GLP-1 therapeutics, metabolic disease